Suncare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-07-2024
- Paid Up Capital ₹ 0.95 M
as on 24-07-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.70 Cr
as on 24-07-2024
- Satisfied Charges ₹ 2.24 Cr
as on 24-07-2024
- Revenue 2.90%
(FY 2023)
- Profit -52.04%
(FY 2023)
- Ebitda -45.60%
(FY 2023)
- Net Worth 3.34%
(FY 2023)
- Total Assets -23.77%
(FY 2023)
About Suncare Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹4.70 Cr. The company has closed loans amounting to ₹2.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Sikaria and Sandeep Sikaria serve as directors at the Company.
- CIN/LLPIN
U31104UT2002PTC017112
- Company No.
094759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2002
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Suncare Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Sikaria  | Director | 18-Jun-2002 | Current |
| Sandeep Sikaria | Director | 18-Jun-2006 | Current |
Financial Performance of Suncare Pharmaceuticals.
Suncare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.9% increase. The company also saw a substantial fall in profitability, with a 52.04% decrease in profit. The company's net worth moved up by a moderate rise of 3.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suncare Pharmaceuticals?
In 2023, Suncare Pharmaceuticals had a promoter holding of 81.05% and a public holding of 18.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suncare Formulations Private LimitedActive 20 years 2 monthsSanjay Sikaria and Sandeep Sikaria are mutual person
Suncare Laboratories LlpActive 3 years 5 monthsSanjay Sikaria and Sandeep Sikaria are mutual person
- Fulwari Greens Properties Private LimitedActive 10 years 4 months
Sanjay Sikaria and Sandeep Sikaria are mutual person
- Uni-Scientific Research And Analytical FoundationActive 3 years 2 months
Sanjay Sikaria is a mutual person
Charges (Loans)
₹47.00 M
₹22.40 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 4.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2020 | Axis Bank Limited | ₹4.00 Cr | Open |
| 19 Aug 2020 | Axis Bank Limited | ₹7.00 M | Open |
| 09 Oct 2009 | Bank Of Baroda | ₹2.24 Cr | Satisfied |
How Many Employees Work at Suncare Pharmaceuticals?
Suncare Pharmaceuticals has a workforce of 5 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suncare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suncare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
